ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $14,169,000 | -9.0% | 1,437,028 | 0.0% | 1.14% | -5.3% |
Q4 2020 | $15,577,000 | +5.2% | 1,437,028 | 0.0% | 1.20% | -9.7% |
Q3 2020 | $14,801,000 | -50.7% | 1,437,028 | 0.0% | 1.33% | -49.6% |
Q2 2020 | $30,005,000 | +140.3% | 1,437,028 | +12.4% | 2.64% | +86.1% |
Q1 2020 | $12,489,000 | +304.0% | 1,278,328 | +376.4% | 1.42% | +173.4% |
Q4 2019 | $3,091,000 | – | 268,343 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |